NCT05905614View on ClinicalTrials.gov

Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 3, 2020

Primary Completion Date

October 26, 2023

Study Completion Date

October 26, 2023

Conditions
Advanced Solid Tumors
Interventions
DRUG

SPH4336 Tablets

Open-label SPH4336 Tablets ：Administered by oral

Trial Locations (4)

100142

Peking University Cancer Hospital, Beijing

250013

Jinan Central Hospital, Jinan

400030

Chongqing University Cancer Hospital, Chongqing

610044

West China Hospital，Sichuan University, Chengdu

All Listed Sponsors
lead

Shanghai Pharmaceuticals Holding Co., Ltd

INDUSTRY

NCT05905614 - Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors | Biotech Hunter | Biotech Hunter